Ganan-Gomez, Irene http://orcid.org/0000-0001-8354-3139
Yang, Hui
Ma, Feiyang http://orcid.org/0000-0002-6260-0787
Montalban-Bravo, Guillermo
Thongon, Natthakan
Marchica, Valentina
Richard-Carpentier, Guillaume
Chien, Kelly http://orcid.org/0000-0001-6024-1613
Manyam, Ganiraju http://orcid.org/0000-0001-6006-8961
Wang, Feng
Alfonso, Ana
Chen, Shuaitong
Class, Caleb http://orcid.org/0000-0003-3130-3613
Kanagal-Shamanna, Rashmi http://orcid.org/0000-0001-7829-5249
Ingram, Justin P.
Ogoti, Yamini
Rose, Ashley
Loghavi, Sanam http://orcid.org/0000-0001-8980-3202
Lockyer, Pamela
Cambo, Benedetta
Muftuoglu, Muharrem http://orcid.org/0000-0001-8100-8554
Schneider, Sarah http://orcid.org/0000-0001-7027-7978
Adema, Vera http://orcid.org/0000-0001-6051-4378
McLellan, Michael http://orcid.org/0000-0002-2703-8784
Garza, John
Marchesini, Matteo
Giuliani, Nicola http://orcid.org/0000-0003-3457-3774
Pellegrini, Matteo http://orcid.org/0000-0001-9355-9564
Wang, Jing http://orcid.org/0000-0002-5398-0802
Walker, Jason http://orcid.org/0000-0001-7547-5789
Li, Ziyi http://orcid.org/0000-0001-8359-0533
Takahashi, Koichi http://orcid.org/0000-0002-8027-9659
Leverson, Joel D.
Bueso-Ramos, Carlos
Andreeff, Michael http://orcid.org/0000-0002-1144-1958
Clise-Dwyer, Karen
Garcia-Manero, Guillermo http://orcid.org/0000-0002-3631-2482
Colla, Simona http://orcid.org/0000-0001-6583-8910
Funding for this research was provided by:
Leukemia and Lymphoma Society (Scholar to Simona Colla)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P50 CA100632)
Edward P. Evans Foundation (NA)
Article History
Received: 10 August 2021
Accepted: 13 January 2022
First Online: 3 March 2022
Change Date: 28 April 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-022-01827-x
Competing interests
: S.C. and M.A. report research funding from AbbVie and Amgen. J.P.I. and J.D.L. worked at AbbVie at the time of the study; G.G.-M. reports clinical funding from AbbVie and Amgen. All other authors report no competing interests related to this study.